Search

Search results

Current filters: HIV, Treatment, Research summary, English

208 search results

Isentress HD—a new once-daily formulation of raltegravir approved in Canada

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

2017, CATIE
Research summary - Webpage

A nurse-led adherence intervention for HIV works and saves money

2017, CATIE
Research summary - Webpage

Do integrase inhibitors affect testosterone levels in men?

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage

Doravirine vs. darunavir

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage

A new nuke in the works—GS-9131

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage

Bictegravir in the body—preliminary information about drug interactions

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage

Bictegravir—an emerging integrase inhibitor

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage

The capsid inhibitor—a new class to enter clinical trials

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage

New drugs, new hope and possible timelines

From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage